Ashish Pemawat: Is the 4.5-Hour Thrombolysis Window Becoming Less Relevant?
Ashish Pemawat, Associate Director of Institute of Neurosciences, shared on LinkedIn about a recent article by Ahmet Günkan et al, published in Stroke, adding:
”Is the 4.5-hour thrombolysis window becoming less relevant?
A recent meta-analysis published in Stroke (2025) pooled data from 8 randomized controlled trials involving 1,742 patients with acute ischemic stroke treated beyond the conventional 4.5-hour window.
Intravenous thrombolysis increased the odds of:
- Excellent functional outcome (mRS 0–1): OR 1.43
- Functional independence (mRS 0–2): OR 1.36
Additional benefits included higher rates of recanalization, reperfusion, and early neurological improvement.
As expected, symptomatic intracerebral hemorrhage was more frequent (OR 4.25), but importantly, there was no statistically significant increase in 90-day mortality.
The key message is clear: patient selection matters more than the clock.
Advanced imaging techniques—particularly perfusion imaging and DWI-FLAIR mismatch—can identify salvageable brain tissue and safely expand access to thrombolysis for selected patients presenting well beyond 4.5 hours or with wake-up stroke.
As stroke care continues to evolve, the paradigm is increasingly shifting from a rigid time-window approach toward a tissue-window approach, allowing more patients to benefit from reperfusion therapy.”
Title: Thrombolysis for Ischemic Stroke Beyond the 4.5-Hour Window: A Meta-Analysis of Randomized Clinical Trials
Authors: Ahmet Günkan, Marcio Yuri Ferreira, Marina Vilardo, Luca Scarcia, Jhon E. Bocanegra-Becerra, Leonardo Januario Campos Cardoso, Luis F. Fabrini Paleare, Gustavo de Oliveira Almeida, Gabriel Semione, Christian Ferreira, Gabriele Ciccio, Adnan Mujanovic, Pascal Jabbour, Yafell Serulle, Thanh N. Nguyen, Jean-Claude Baron

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 25, 2026, 18:00The Evolving Landscape of Factor Replacement Therapy – EAHAD
-
Jul 25, 2026, 17:43Heghine Khachatryan: Advancing Care for Women and Girls With Hemophilia
-
Jul 25, 2026, 17:00Revathy R Menon: A Memorable Milestone at the 39th ISBT Congress
-
Jul 25, 2026, 16:19Nicola Potere: From Scientific Exchange to Global Collaboration at ISTH 2026
-
Jul 25, 2026, 12:11Salma Abosabie: Honored to Have an Oral Presentation on Thromboinflammation at the ISTH 2026
-
Jul 25, 2026, 12:06Christina Hart: New Review on Coagulation Disorders in Philadelphia Chromosome-Negative MPNs
-
Jul 25, 2026, 11:57Leonard Valentino: Excited to Share The New Perspectives on Hemophilic Arthropathy
-
Jul 25, 2026, 11:49Meaghan O’Donnell: Highlighting Global Gaps in Haemophilia Carrier Registration at ISTH 2026
-
Jul 25, 2026, 11:43Emmanuel J Favaloro: Honored with the JTH Distinguished Peer Review Award